Efficacy of Diet and Hypnotic Suggestions or Telemedicine in Obesity Management
NCT ID: NCT03811197
Last Updated: 2020-05-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
90 participants
INTERVENTIONAL
2017-10-13
2019-12-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study will cover a group of 90 adult patients, both sexes, with obesity (BMI ≥30 kg/m\^2) undergoing MNT a dietetic treatment. Three arms are planned in the study scheme, according to the scheme: Group 1 - individual MNT (30 people); Group 2 -individual MNT and T (30 people); Group 3 - individual MNT and HS (30 people).
The authors hope that the results of the study will allow to develop a new model of the most effective management of obesity, resulting in weight reduction and maintaining this effect over time. The results obtained during the study will also allow to assess the impact of the therapy applied on lifestyle changes, dietary habits and the knowledge about the disease among obese patients.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hypnosis, Self-hypnosis and Weight Loss in Obese Patients
NCT02292108
Telemedical Coaching for Weight Loss
NCT01837134
CBT-based and Motivational Interviewing Supported Psychoeducation in Obese Individuals
NCT06632171
Study of Five Different Methods Of Delivering A Lifestyle Modification Program for Weight Loss
NCT00471172
Remote Weight Management Program for Obese Women
NCT05635097
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study covers a group of 90 adults, both sexes, with obesity (BMI ≥30 kg/m\^2), undergoing individual MNT, randomly assigned to one of three groups for 6 months (Part A): Group 1 - individual MNT (30 people); Group 2 - individual MNT and T (30 people); Group 3 - individual MNT and HS (30 people). All subjects will continue the program for additional 6 months (Part B follow up).
The selection of subjects for the study is purposeful and the participation in the study is voluntary. All subjects are educated to follow a reduced calorie Dietary Approaches to Stop Hypertension diet ("DASH") for 6 months (Part A). Education materials (handouts and sample meal plans) are provided to the subjects.
The primary and secondary outcomes will be evaluated at baseline, months 1,2,3,4,5, 6 (Part A) and months 9, 12 (Part B follow up).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
individual MNT
Dietary counseling via face to face meeting
Dietary counseling via face to face meeting
All subjects received individual MNT and individual dietary recommendations based on DASH (Dietary Approaches to Stop Hypertension) diet plan for 6 months (Part A). Dietary counseling is provided by a trained dietitian. Months 9 and 12 - follow up (Part B).
Individual MNT and T
Dietary counseling via face to face meeting and Telemedicine
Dietary counseling via face to face meeting
All subjects received individual MNT and individual dietary recommendations based on DASH (Dietary Approaches to Stop Hypertension) diet plan for 6 months (Part A). Dietary counseling is provided by a trained dietitian. Months 9 and 12 - follow up (Part B).
Telemedicine
All subjects received an additional dietary counseling for 6 months (via internet, messenger or telephone) two weeks after each standard visit will be added to the counseling (Part A). Standard and additional dietary counseling (T) are provided by a trained dietitian. Months 9 and 12 - follow up (Part B).
Individual MNT and HS
Dietary counseling via face to face meeting and Hypnotic Suggestions
Dietary counseling via face to face meeting
All subjects received individual MNT and individual dietary recommendations based on DASH (Dietary Approaches to Stop Hypertension) diet plan for 6 months (Part A). Dietary counseling is provided by a trained dietitian. Months 9 and 12 - follow up (Part B).
Hypnotic Suggestions
All subjects received individual hypnotic suggestion (HS) for 6 months as a supplementary method for dietary counseling. HS will be adapted to the "small steps" method used in the management of obesity. During the visit, HS will be recorded and the individual will listen to it every day (Part A). HS will be provided by a physician, qualified in the field of hypnotherapy. Months 9 and 12 - follow up (Part B).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dietary counseling via face to face meeting
All subjects received individual MNT and individual dietary recommendations based on DASH (Dietary Approaches to Stop Hypertension) diet plan for 6 months (Part A). Dietary counseling is provided by a trained dietitian. Months 9 and 12 - follow up (Part B).
Telemedicine
All subjects received an additional dietary counseling for 6 months (via internet, messenger or telephone) two weeks after each standard visit will be added to the counseling (Part A). Standard and additional dietary counseling (T) are provided by a trained dietitian. Months 9 and 12 - follow up (Part B).
Hypnotic Suggestions
All subjects received individual hypnotic suggestion (HS) for 6 months as a supplementary method for dietary counseling. HS will be adapted to the "small steps" method used in the management of obesity. During the visit, HS will be recorded and the individual will listen to it every day (Part A). HS will be provided by a physician, qualified in the field of hypnotherapy. Months 9 and 12 - follow up (Part B).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject is diagnosed with obesity (BMI ≥ 30 kg / m\^2 at the screening visit).
* Subject understands the study procedures and is able to give written informed consent.
Exclusion Criteria
* Subject is a pregnant women or a breast-feeding mother; or subject is planning to be pregnant during the study period
* Subject is suffering from chronic liver diseases or renal failure
* Subject has untreated or uncompensated thyroid diseases
* Subject has a history of presence of mental disorders
* Subject has a history of presence of epilepsy
* Subject has a history of presence of cancer
* Any other uncontrolled physical or psychological condition that increases significantly the health risks for the subject
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Warsaw University of Life Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Danuta Gajewska
Principal Investigator, Adjunct Professor at the Department of Dietetics,PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Danuta Gajewska, PhD
Role: PRINCIPAL_INVESTIGATOR
Department of Dietetics, Warsaw University of Life Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Human Nutrition and Consumer Sciences of the Warsaw University of Life Sciences
Warsaw, , Poland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Hipnoza2019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.